Document is current
Any future updates will be listed below
-
Authors
Li, Zhongchi
Low, Vivien https://orcid.org/0000-0002-8561-011X
Luga, Valbona
Sun, Janet
Earlie, Ethan
Parang, Bobak
Shobana Ganesh, Kripa
Cho, Sungyun
Endress, Jennifer
Schild, Tanya
Hu, Mengying https://orcid.org/0000-0002-0358-6014
Lyden, David https://orcid.org/0000-0003-0193-4131
Jin, Wenbing
Guo, Chunjun
Dephoure, Noah https://orcid.org/0000-0001-5802-2657
Cantley, Lewis C. https://orcid.org/0000-0002-1298-7653
Laughney, Ashley M.
Blenis, John https://orcid.org/0000-0003-3622-2337
- License Information
-
More Information
Article History
Received: 18 January 2022
Accepted: 5 October 2022
First Online: 20 October 2022
Competing interests
: L.C.C. owns equity in, receives compensation from and serves on the board of directors and scientific advisory board of Agios Pharmaceuticals and Petra Pharma Corporation. The other authors declare no competing interests.
